Form 8-K - Current report:
SEC Accession No. 0001213900-24-105782
Filing Date
2024-12-05
Accepted
2024-12-05 08:45:39
Documents
31
Period of Report
2024-12-05
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0223706-8k_protara.htm   iXBRL 8-K 36036
2 INVESTOR PRESENTATION, DATED DECEMBER 5, 2024 ea022370601ex99-1_protara.htm EX-99.1 21511
3 PRESS RELEASE, DATED DECEMBER 5, 2024 ea022370601ex99-2_protara.htm EX-99.2 21618
4 POSTER PRESENTATION, DATED DECEMBER 5, 2024 ea022370601ex99-3_protara.htm EX-99.3 8582
5 GRAPHIC ex99-1_001.jpg GRAPHIC 371096
6 GRAPHIC ex99-1_002.jpg GRAPHIC 862339
7 GRAPHIC ex99-1_003.jpg GRAPHIC 450165
8 GRAPHIC ex99-1_004.jpg GRAPHIC 434678
9 GRAPHIC ex99-1_005.jpg GRAPHIC 547590
10 GRAPHIC ex99-1_006.jpg GRAPHIC 541732
11 GRAPHIC ex99-1_007.jpg GRAPHIC 565094
12 GRAPHIC ex99-1_008.jpg GRAPHIC 668574
13 GRAPHIC ex99-1_009.jpg GRAPHIC 520649
14 GRAPHIC ex99-1_010.jpg GRAPHIC 333098
15 GRAPHIC ex99-1_011.jpg GRAPHIC 257102
16 GRAPHIC ex99-1_012.jpg GRAPHIC 537386
17 GRAPHIC ex99-1_013.jpg GRAPHIC 532669
18 GRAPHIC ex99-2_001.jpg GRAPHIC 2472
19 GRAPHIC ex99-3_001.jpg GRAPHIC 871252
  Complete submission text file 0001213900-24-105782.txt   10603391

Data Files

Seq Description Document Type Size
20 XBRL SCHEMA FILE tara-20241205.xsd EX-101.SCH 3018
21 XBRL LABEL FILE tara-20241205_lab.xml EX-101.LAB 34240
22 XBRL PRESENTATION FILE tara-20241205_pre.xml EX-101.PRE 22361
33 EXTRACTED XBRL INSTANCE DOCUMENT ea0223706-8k_protara_htm.xml XML 3691
Mailing Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010 646-844-0337
Protara Therapeutics, Inc. (Filer) CIK: 0001359931 (see all company filings)

EIN.: 204580525 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36694 | Film No.: 241527947
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)